Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neoplasm
Key facts
- Who runs it
- Fred Hutchinson Cancer Center
- Where
- Seattle, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 1 Sept 2025
- Ended
- 1 Jan 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Best Practice
- Palliative Care Consultation
- Survey Administration
- Tumor Board Review
- Record updated
- 29 June 2025
- Why it stopped
- Study closed before opening to accrual; Insufficient staff
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (9)Hide the full registry criteria
Who can take part
- Adults (18 years or older)
- Pancreatic neoplasm pathology
- Ability to read, write, and speak in English
- Has decisional capacity
- Expected to be seen and discussed at PCSC and seeing a surgeon as part of their tumor board evaluation
Who cannot take part
- Currently is or previously has received palliative care, or are unwilling to forego palliative care for the first 90 days post randomization
- Evidence of any behavior, condition, or circumstance (including, but not limited to: blindness, deafness, serious behavior or mental health conditions, discontinuing curative treatment, lack of access to technology, etc) that would interfere with their ability to complete study procedures as noted within the chart
- Metastatic pancreatic neoplasm
- Currently incarcerated
Where in United States
- Fred Hutch/University of Washington Cancer ConsortiumSeattle, United States
About the trial
What the trial wants to find out
This clinical trial evaluates a palliative care consultation for improving communication between providers and patients considering surgery for a pancreatic neoplasm. Pancreatic operations have known complications that can affect quality of life. Palliative care has been shown to improve patient reported quality of life and functional outcomes. Receiving a palliative care consultation may improve communication and decision making for patients considering surgery for a pancreatic neoplasm.
The 2 groups in the trial
- Arm I (Usual care)Existing treatment, for comparison
Patients receive usual care and undergo evaluation by a tumor board within 14 days of baseline.
Treatment: Best Practice, Survey Administration, and Tumor Board Review
- Arm II (Palliative care visit)Treatment being tested
Patients attend a palliative care visit over 60 minutes to discuss their illness, quality of life, fears and concerns and communication preferences within 7 days of baseline. Patients also undergo evaluation by a tumor board within 14 days of baseline.
Treatment: Palliative Care Consultation, Survey Administration, and Tumor Board Review
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Preoperative, Specialty Palliative Care for Patients Considering Pancreatic Surgery: Pilot Feasibility and Acceptability Study
- Record updated
- 29 June 2025